At the news
? BEARISHIMPACT 5/10 PRESS-RELEASE filed Aug 5, 2026 at 08:45 ET
BiomX acquired a 10% stake in Motomea for $50,000 cash plus 1.3M restricted shares (pending NYSE approval), gaining access to electric motor testing and drone propulsion validation capabilities. The deal is tiny relative to the company's severe financial distress and massive ATM dilution risk, making it a negligible strategic move that does not address the existential cash crunch.
- BiomX acquired a 10% stake in Motomea for $50,000 cash and 1.3M restricted shares (subject to NYSE approval)
- The deal includes an option to acquire control of Motomea at 2x net revenue (FY2027) or 4x EBITDA (FY2028), times 90%
- BiomX has a market cap of ~$5M and is in severe financial distress, with a $9.145M ATM offering that could dilute shares by over 450%
- The company has a going concern qualification and faces potential NYSE American delisting
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access